AGLE - Aeglea Bio up 10% premarket after pricing equity offering April, 28 2020 09:19 AM Aeglea BioTherapeutics Inc. Aeglea BioTherapeutics (NASDAQ:AGLE) has priced its public offering of 11,652,830 common shares at $4.75/share.More news on: Aeglea BioTherapeutics, Inc., Healthcare stocks news, , Stocks on the move, Read more ...